Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexamethasone for Post-Endodontic Pain in Irreversible Pulpitis
NCT06432712Phase 1Not yet recruiting
- Start
- Jan 2025
- Primary completion
- Jan 2025
- Modality
- Orthosteric Ligands
01
Overview
Phase 1, randomised trial of dexamethasone in irreversible pulpitis (2 arms). Primary endpoint: Post operative pain at 1 week. Planned start Jan 2025; status: not yet recruiting.
02
Drugs
dexamethasone
03
Conditions
irreversible pulpitis
Beyond the preview
Go deeper on NCT06432712.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06432712.